How exciting to be part of this!

Finally reunited …. ESRU meeting in Prague. What a pleasure to see you all. European Association of Urology (EAU)

Enjoyed writing this w Mutie Raslan & Clàudia Mercader #STHLM3_MRI an exciting progression in direct use of #mpMRI in #ProstateCancer screening Looking 4wd to BJU International session @ #AUA22 where Hashim U. Ahmed & Matt Cooperberg debate this alongside STHLM3 lead Henrik Gronberg

Clàudia Mercader talks to Oxford Prostate Cancer Support Group #OPCSG about "Why come from Barca to Oxford to do a fellowship?" 5 lessons learned: •not only 1 way to do things •ask why •involve ur pts •learn from ur results •England is more than just London! #Oxford_Urology

Congrats Clàudia Mercader 🍾 Doing great work as one of our pelvic fellows keeping the #Oxford_Urology trials portfolio in the road...and also delivering in spades as our BJU International reviewer of the month!! Were going to miss you when Maria J. Ribal & Antoni Vilaseca get you back!

Mutie Raslan presents #Oxford_Urology data on 18F #PSMA_PET in Primary & Secondary staging of #ProstateCancer •n=354 (1°); similar to #PRIMARY_Trial data but concerning false +ves •n=466 (2°); equivalent detection rates to 68Ga #BAUS22

Couldn’t have asked for better companions on this journey

My journey as an Uro-oncology Pelvic Fellow in Oxford University Hospitals has come to an end. Bitter-sweet feelings as I travel back home, but grateful for all the people I’ve met, lessons learned and both personal and professional growth. Ready for the next stage!

Demà!!! No et perdis la sessió gratuïta organitzada per l'Oficina del Pacient de la Societat Catalana d'Urologia i suma't a #Movember ! SCU

.Nikita Bhatt discusses how social media interventions can be utilized in urology. #urology #urologist #UroSoMe Watch now: urologytimes.com/view/dr-bhatt-…

Absolutely grateful to work in this outstanding #urology department. Always embracing #Innovation and following the tradition of recognised Prof. Gilvernet school. Never stop learning and giving the best for our patients. And with a very special spirit: Hospital Clínic brand.

Interesting experience at #PROSCA23. Engaging discussions, thought-provoking sessions led by multidisciplinary experts and a shared commitment to improve patient outcomes and quality of life. #ProstateCancer

Grateful for the professional and personal growth during my time at the Pelvic Uro-Oncology Fellowship 🚀 Check out the opportunity to join this program surrounded by an incredible team #Oxford_Urology

🎥Antoni Vilaseca, MD, of Hospital Clínic discusses the potential of TAR-210, a bladder-inserted drug delivery system, for NMIBC. Promising safety profile suggests reduced need for surgery: 📷ow.ly/ZY5B50QgWTy📷 #ESMO23 #UroOnc #UroSoMe #BlcSM

One day your are swimming in the deep blue sea, the other day in the deep molecular science 🧬 🐋 #urology #research #uroscience

A new era is coming for the treatment of NMIBC. Don’t miss this updated summary European Urology Oncology authors.elsevier.com/c/1jDEc9Cfv--d…

Our #StatisticalAnalysisPlan now published in BMC #Trials #NotLongNow!! SITU Oxford OCTRU Trials Hub Nuffield Department of Surgical Sciences trialsjournal.biomedcentral.com/articles/10.11…

What an amazing 3 days in Budapest at the #UROonco24, plenty of interesting discussions about the hot topics in uro-oncology and also blessed to have taken part in the STEPS program to discuss about #bladdercancer and #UTUC with experts like Jeremy Teoh and Evanguelos Xylinas

The IDENTIFY BURST Urology risk calculator predicts urinary tract cancer using patient characteristics. ⭕️It stratifies haematuria patients into very-low-risk, low-risk, intermediate-risk, and high-risk groups. 📈External validation involved 3582 patients, achieving an AUC of

Really like this little paper we've published in the brilliant new BJUI Compass on 10 yrs of #ASAP at #Oxford_Urology. THM - not all subsequent biopsies after ASAP are #LowGrade. In fact 24.1% had GG≥2 within 2yrs of diagnosis of ASAP. Thines Krishna doi.org/10.1002/bco2.4…